Jill Marie Broadfoot - May 21, 2021 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Chief Financial Officer
Signature
Nancy Denyes, attorney-in-fact
Stock symbol
LIFE
Transactions as of
May 21, 2021
Transactions value $
$0
Form type
4
Date filed
5/25/2021, 09:04 PM
Next filing
Aug 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LIFE Common stock 10K May 21, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Employee Stock Option (Right to buy) Award $0 +54K $0.00 54K May 21, 2021 Common Stock 54K $4.45 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 178 shares acquired under that Company's 2015 Employee Stock Purchase Plan on May 17, 2021.
F2 The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2025. This option is subject to accelerated vesting upon termination without cause upon change of control of the issuer.